Cynosure Group’s Illumina ILMN Stock Holding History

Cynosure Group’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,228	Closed	-$431K	–	153
2023 Q3	$431K	Sell	3,228 -74	-2%	-$12.2K	0.13%	114
2023 Q2	$602K	Buy	+3,302	New	+$668K	0.18%	98

Other funds holding ILMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cynosure Group's ILMN Position: Q4 2023 in Review

Cynosure Group sold out of Illumina (ILMN) in Q4 2023, closing a stake of 3,228 shares — an estimated $431K sold.

Cynosure Group first reported a position in ILMN in Q2 2023 and held it in 2 quarters. The position peaked at $602K in Q2 2023. 810 funds tracked by Wall St. Rank hold ILMN as of Q4 2023.

Cynosure Group reported no remaining Illumina position as of Q4 2023 after selling out during the quarter.
Cynosure Group sold 3,228 Illumina shares in Q4 2023, an estimated $431K.
Cynosure Group first reported a position in Illumina in Q2 2023 and held it in 2 quarters.
Cynosure Group's Illumina position peaked at $602K in Q2 2023.
810 funds tracked by Wall St. Rank held Illumina as of Q4 2023.

Based on Cynosure Group's 13F filing for Q4 2023, filed 14 Feb 2024.